otsuka pharmaceutical co ltd
Your Gut Bacteria Could Affect How Drugs Work For You
Microorganisms in the gut likely have an effect on how the body metabolizes drugs, according to a new study.
GHIT Announces Ten New Funding Partnerships
The Global Health Innovative Technology Fund has ten new funding partners that include major global pharmaceutical and biotechnology companies.
Otsuka Acquires Leukemia Drug Dacogen® From Eisai
Otsuka Pharmaceutical acquires two drugs, Dacogen® and E7727, from Eisai Co. to enhance their leukemia drug portfolio.
Otsuka Pharma Completes Acquisition Of Astex Pharma For US$886m
Otsuka Pharma has successfully completed its acquisition of Astex Pharmaceuticals, Inc. for US$8.50 per share.
Otsuka Pharma To Acquire Astex Pharma For US$866m
Otsuka Pharma has acquired Astex Pharma via an all-cash tender offer of US$866 million.
Otsuka, Lundbeck Present Lu AE58054 Phase II Data For Alzheimer’s Disease
H. Lundbeck A/S and Otsuka Pharma announced Phase II clinical data on their Lu AE58054 investigational drug for moderate Alzheimer's disease.
